N. Munoz and F. Bosch, Epidemiologic classification of human papillomavirus types associated with cervical cancer, The New England journal of medicine.N.Engl.J.Med, vol.3486, pp.518-545, 2003.

D. Riethmuller, J. P. Scaal, and C. Mougin, ??pid??miologie et histoire naturelle de l???infection g??nitale ?? papillomavirus humain, Gyn??cologie Obst??trique & Fertilit??, vol.30, issue.2, pp.139-146, 2002.
DOI : 10.1016/S1297-9589(01)00282-X

J. Prétet, A. Jacquart, X. Carcopino, J. Charlot, D. Bouhour et al., Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study, International Journal of Cancer, vol.367, issue.Suppl 3, pp.428-432, 2008.
DOI : 10.1002/ijc.23092

N. Muñoz, F. Bosch, . Castellsagué, . Díaz, . Silvia-de-sanjose et al., Against which human papillomavirus types shall we vaccinate and screen? the international perspective, International Journal of Cancer, vol.183, issue.2, pp.278-285, 202004.
DOI : 10.1002/ijc.20244

D. Forman, C. De-martel, and C. Lacey, Global Burden of Human Papillomavirus and Related Diseases, Vaccine, vol.30, 2012.
DOI : 10.1016/j.vaccine.2012.07.055

V. Dalstein, J. Briolat, P. Birembaut, and C. Clavel, Epidemiologie des infections génitales à papillomavirus. La revue du patricien, Nov, vol.15, pp.1857-1881, 2006.

N. Duport, Données épidémiologiques sur le cancer du col de l'utérus ; Etat des connaissances. Actualisation, 2008.

J. Ferlay, F. Bray, P. Pisani, D. Parkin, and . Globocan, Cancer incidence, Moratilty and Prevalence worldwide. IARC CancerBase N5 version 2, 2002.

B. Donovan, R. Guy, A. Grulich, D. Regan, and H. Ali, Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, The Lancet Infectious Diseases, vol.11, issue.1, pp.39-44, 2011.
DOI : 10.1016/S1473-3099(10)70225-5

J. Fagot, A. Boutrelle, P. Ricordeau, A. Weill, and H. Allemand, HPV vaccination in France: Uptake, costs and issues for the National Health Insurance, Vaccine, vol.29, issue.19, pp.3610-3616, 2011.
DOI : 10.1016/j.vaccine.2011.02.064

G. Pelissier and F. Bastides, HPV vaccine and cervical cancer prevention in general practice Survey conducted among general practitioners in the French departments of Eure-et-Loire and Cher, Rev.Prat, vol.58, pp.25-31, 2008.

L. Piana, Opinions et pratiques des m??decins g??n??ralistes face ?? la vaccination anti-Papillomavirus, M??decine et Maladies Infectieuses, vol.39, issue.10, pp.789-97, 2009.
DOI : 10.1016/j.medmal.2009.08.007

D. Lutringer-magnin, Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing, Vaccine, vol.29, issue.32, pp.5322-5330, 2011.
DOI : 10.1016/j.vaccine.2011.05.006

URL : https://hal.archives-ouvertes.fr/hal-00698034

N. Nicolay, D. Levy-bruhl, L. Fonteneau, and M. Jauffret-roustide, Vaccination : perceptions et attitudes, Connaissances, attitudes et comportements face au risque infectieux. Saint-Denis : Inpes, pp.89-101, 2006.

G. Chambon and R. Charles, Vacciner contre l'hépatite B ? Ce qu'en disent des parents et des médecins de l'agglomération stéphanoise, Medicine, vol.7, pp.333-340, 2011.

M. Poltoraka, M. Leach, J. Fairhead, and J. Cassell, ???MMR talk??? and vaccination choices: An ethnographic study in Brighton, Social Science & Medicine, vol.61, issue.3, pp.709-728, 2005.
DOI : 10.1016/j.socscimed.2004.12.014

A. Benin, D. Wisler-scher, E. Colson, E. Shapiro, and E. Holmboe, Qualitative Analysis of Mothers' Decision-Making About Vaccines for Infants: The Importance of Trust, PEDIATRICS, vol.117, issue.5, pp.1532-1573, 2006.
DOI : 10.1542/peds.2005-1728

M. Amouyal, M. Vallart, G. Bourrel, and A. Oude-engberink, Que pensent les parents de la vaccination? Une étude qualitative

C. Davison, Lay epidemiology and the prevention paradox : the implications of coronary candidacy for health education, Sociology of Health & Illness, vol.13, 1991.

N. Bajos and M. Bozon, Enquête sur la sexualité en France, 2008.

M. Blais, S. Raymond, H. Manseau, J. Otis, and J. Lavigne, La sexualité des jeunes Québécois et Canadiens

A. Gaudineau, V. Ehlinger, N. Gabhainn, S. Vayssiere, C. Arnaud et al., Use of emergency contraceptive pill by 15-year-old girls: results from the international Health Behaviour in School-aged Children (HBSC) study, BJOG: An International Journal of Obstetrics & Gynaecology, vol.108, issue.1, pp.1197-1204, 2010.
DOI : 10.1111/j.1471-0528.2010.02637.x

URL : https://hal.archives-ouvertes.fr/inserm-00506135

K. Wellings, K. Nanchahal, W. Macdowall, S. Mcmanus, B. Erens et al., Sexual behaviour in Britain: early heterosexual experience, The Lancet, vol.358, issue.9296, pp.1843-1850, 2001.
DOI : 10.1016/S0140-6736(01)06885-4

D. Garriguet, Relations sexuelles précoces Rapport sur la santé, Statistiques Canada, vol.16, issue.3, pp.11-21, 2005.

N. Gabhainn, S. Baban, A. Boyce, W. Godeau, and E. , How Well-protected are Sexually Active 15-year Olds? Cross-national Patterns in Condom and Contraceptive Pill Use, International Journal of Public Health, vol.54, issue.2, pp.1-7, 2002.

G. Pelisser and F. Basties, HPV vaccine and cervical cancer prevention in general practice.Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher, Rev.Prat, vol.58, pp.25-31, 2008.

L. Piana, Opinions et pratiques des m??decins g??n??ralistes face ?? la vaccination anti-Papillomavirus, M??decine et Maladies Infectieuses, vol.39, issue.10, pp.789-97, 2009.
DOI : 10.1016/j.medmal.2009.08.007

D. Lutringer-magnin, Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing, Vaccine, vol.29, issue.32, pp.5322-5330, 2011.
DOI : 10.1016/j.vaccine.2011.05.006

URL : https://hal.archives-ouvertes.fr/hal-00698034

A. Jacquet, S. Ouaret, and C. Kreft-jaïs, Danger et risques des vaccins: mythes et réalités « La pharmacovigilance des vaccins ». Adsp n°71 juin, pp.37-39, 2010.

L. Grimaldi-besouda, Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. Accepted for publication, J Intern Med, 2013.

C. P. Chao, Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine, Journal of Internal Medicine, vol.302, issue.2, pp.193-203, 2012.
DOI : 10.1111/j.1365-2796.2011.02467.x

D. Torny, De l'obligation vaccinale à la recommandation. ADSP n°71 juin, pp.16-18, 2010.

B. Donovan, N. Franklin, R. Guy, A. Grulich, D. Regan et al., Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, The Lancet Infectious Diseases, vol.11, issue.1, pp.39-44, 2011.
DOI : 10.1016/S1473-3099(10)70225-5

T. Read, J. Hocking, M. Chen, B. Donovan, C. Bradshaw et al., The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme, Sexually Transmitted Infections, vol.87, issue.7, pp.10-1136, 2011.
DOI : 10.1136/sextrans-2011-050234

J. Brotherton, M. Fridman, C. May, G. Chappell, A. Saville et al., Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study, The Lancet, vol.377, issue.9783, pp.2085-92, 2011.
DOI : 10.1016/S0140-6736(11)60551-5

E. Lefevere, N. Hens, H. Theeten, B. Van-den, P. Beutels et al., Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium), Vaccine, vol.29, issue.46, 2011.
DOI : 10.1016/j.vaccine.2011.08.039

S. Skinner, Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study, The Lancet, vol.384, issue.9961, pp.140-673660920, 2014.
DOI : 10.1016/S0140-6736(14)60920-X

P. Castle and K. Schmeler, HPV vaccination: for women of all ages ? Lancet, 2014; publication avancée en ligne le 2 septembre. Doi:.10, pp.140-673661230, 1016.